N itric oxide (NO) exerts diverse regulation of cell signaling 1 through a broad range of post-translational modifications, largely through S-nitrosylation of specific cysteine thiol moieties. [2] [3] [4] Despite the increased understanding of NO signaling and the identification of various NO synthase (NOS) isoforms in the cardiac myocyte, a consensus has not emerged on the mechanism underlying NO regulation of excitation-contraction coupling, and studies have reported diametrically opposite results. For example, NOS1-deficient mice-1 (NOS1 −⁄− ) showed opposite behavior of cardiomyocytes in calcium (Ca 2+ ) handling and contractility 5-7 or sarcoplasmic reticulum (SR) Ca 2+ leak 8,9 in comparison with wild-type (WT) cells. Similarly, studies showed opposite effects on β-adrenergic contractile responses. 1, 7 We hypothesized that other factor(s) can fundamentally change the direction of an NO-based physiological response. Here, we identify temperature as a key determinant of cardiomyocyte response to NO.
Myocyte Isolation
Cardiac myocytes were isolated and prepared from hearts as previously described. 6 Briefly, hearts were harvested and perfused retrogradely in a modified Langendorff system (constant flow, 2 mL/min) with an isolation solution (see Online Data Supplement), bubbled with 5% CO 2 and 95% O 2 for ≥15 minutes. Once cleaned, the hearts were perfused with collagenase type 2 (Worthington Biochemical Corporation, Lakewood, NJ) ≈315 U/mL and protease type XIV (Sigma-Aldrich, St. Louis, MO) 5.2 U/mL for 10 minutes. After digestion, myocytes were released by gentle mechanical disruption. The extracellular Ca 2+ was restored by sequential additions of CaCl 2 in a Ca 2+ -free Tyrode solution (see Online Data Supplement). Cardiomyocytes were resuspended in a 1.8 CaCl 2 Tyrode solution at room temperature and then loaded with Fura-2. Myocytes were stimulated at 0.5 or 1 Hz.
Intracellular Ca 2+ Measurement
Intracellular Ca 2+ was measured using the Ca 2+ -sensitive dye Fura-2 (Molecular Probes, Eugene, OR) and a dual-excitation spectrofluorometer (IonOptix LLC, Milton, MA), excited with a xenon lamp at wavelengths of 340 and 380 nm. The emission fluorescence was reflected through a barrier filter (510±15 nm) to a photomultiplier tube. The in vivo calibration was performed superfusing a free Ca 2+ and then a Ca 2+ saturating (5 mmol/L) solutions both containing 10 μmol/L ionomycin (Sigma-Aldrich) until reaching a minimal (R min ) or a maximal (R max ) ratio values, respectively. [Ca] 2+ i was calculated as described previously. 9 Measurement of SR Ca 2+ Leak and SR Ca 2+ Content SR Ca 2+ leakage was assessed with 1 mmol/L tetracaine (Sigma-Aldrich) as described by Shannon et al. 22 The observed decrease in the Fura-2 ratio in presence of tetracaine compared with the nontetracaine-treated condition was considered the Ca 2+ leak for a particular myocyte (Online Figure I) . After assessing Ca 2+ leak, tetracaine was washed out by superfusing fresh 0Na + /0Ca 2+ Tyrode solution and SR Ca 2+ content was assessed as described by Bassani et al 23 by a caffeine challenge.
SR Ca 2+ contents were calculated considering that SR represents 3.5% and cytosol 65% of the myocyte volume as previously described. 9 SR leak-SR load pairs were grouped by similar SR Ca 2+ load and expressed as a leak-load relationship fitted by an exponential growth function using the Graph Pad Prism software (version 4.02). Measurements were mostly performed at 23°C, 25°C, 30°C, 34°C, or 37°C.
Treatments
Cardiomyocytes loaded with Fura-2 were preincubated for 20 minutes with the following compounds (unless otherwise is specified): Tempol (100 μmol/L; Calbiochem, Calbiochem/EMD Biosciences, San Diego, CA); Oxypurinol (100 μmol/L; Sigma-Aldrich); (±)-S-Nitroso-N-acetylpenicillamine (SNAP; 1 or 50 μmol/L; Santa Cruz, Santa Cruz, CA); N 5 -(1-Imino-3-butenyl)-l-Ornithine (l-VNIO; 100 μmol/L; Enzo Life Sciences, Plymouth Meeting, PA); Hydrogen peroxide (H 2 O 2 ; 100 μmol/L; Sigma-Aldrich) (6R)-5,6,7,8-Tetrahydrobiopterin dihydrochloride (BH 4 ; 300 μmol/L; Sigma-Aldrich). Experiments in control condition (no treatment) were run in parallel to each type of pharmacological intervention for each batch of cardiomyocytes.
Detection of Reactive Oxygen Species
reactive oxygen species (ROS) were measured by using the sensitive probe 2′,7′-dichlorodihydrofluoresceine diacetate (10 μmol/L; Molecular Probes) in 2 different ways. First, fresh isolated mouse cardiomyocytes were placed in the chamber of an IonOptix spectrofluorometer and the background fluorescence (F 0 ) was acquired and then, cardiomyocytes were incubated during 30 minutes at 23°C or 37°C with 2′,7′-dichlorodihydrofluorescein diacetate and washed. The initial fluorescence (F i ) and a second measure after 5 minutes (F) were acquired. Myocytes were stimulated at 1 Hz and ROS expressed as:
Alternatively, control or 100 μmol/L oxypurinol-treated cardiomyocytes were loaded with 2′,7′-dichlorodihydrofluorescein diacetate for 15 minutes on polylysine-coated microscope slides at 23°C or 37°C. After 10 minutes washing with Tyrode solution, cardiomyocytes were fixed with 2% p-formaldehyde in cold phosphate-buffered saline and then washed once with phosphate-buffered saline. Cardiomyocytes treated with 1 mmol/L H 2 O 2 at either 23°C or 37°C, from each mouse model were used as positive control for ROS and were used as maximal fluorescence signal for normalization of each group (F max ). Fluorescence (F) was captured with an excitation wavelength of 488 and 525 nm emission. Images were quantified by ImageJ (National Institutes of Health) software and results were expressed as:
where F 0 is background. 
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Nitric Oxide Measurement
Isolated WT mouse cardiomyocytes were loaded with the NO-sensitive dye 4,5-diaminofluorescein diacetate (5 μmol/L; Calbiochem/EMD Biosciences) for 20 minutes at room temperature. Cells were set in the perfusion chamber of an IonOptix system and fluorescence (excited at 488 nm and emission collected at 510±15 nm) was recorded during stabilization at 23°C. Then, fluorescence was also acquired at 25°C, 30°C, 34°C, and 37°C for each cell; 4,5-diaminofluorescein intensity was expressed as F/F 0 , where F 0 is the fluorescence intensity at 23°C after the stabilization time.
NOS Isoform Expression
Cardiomyocytes from 4 WT hearts were exposed to different temperature and then collected in RNA later lysis buffer (Qiagen, Valencia, CA 
Statistical Analysis
Data are expressed as mean±SEM. For leak-load relationship, an exponential growth fit, which compares independent fits with a global shared fit was applied. Two or more groups of data were considered to fit different curves if P<0.05. For comparisons of 2 groups, Student t test was used. For comparison of ≥3groups, 1-or 2-way ANOVA was performed. Two-way ANOVA was used when a second variable was involved. Newman-Keuls or Bonferroni post hoc tests were used as appropriate by the GraphPad Prism version 4.02 (GraphPad Prism Software Corporation San Diego, CA). A P<0.05 was considered significant.
Results
Leak-Load Relationship is Critically Affected by Temperature
We measured SR Ca 2+ leak (Online Figure I ) in cardiomyocytes from WT and NOS1 −/− (which have depressed S-nitrosylation and oxidative stress) mice over a broad temperature range from 23°C to 37°C. The SR Ca 2+ leak response to changes in temperature was different in these 2 models ( Figure 1A ). The pattern of SR Ca 2+ leak-temperature, at matched SR Ca 2+ load, shows that leak slightly increases (P=0.038) when the temperature is reduced from physiological temperature through 34°C, 30°C, 25°C, and 23°C in WT cardiomyocytes, with the leak at 23°C, being higher than at 37°C ( Figure 1B ; P=0.014 and 2A). In marked contrast, the temperature-dependent change in leak in NOS1 −/− cardiomyocytes was lower compared with WT at low temperature ( Figure 1A and 1B), in agreement with Wang et al. 8 However, NOS1 −/− cardiomyocytes exhibited a significant increase in leak when the temperature surpassed 30°C ( Figure 1A) as we previously showed. 9 This behavior is summarized in Figure 1B , which compares SR Ca 2+ leak in NOS1 −/− at 37°C with 23°C ( Figure 1B ; P=0.0054 and 2A).
Reactive Oxygen Species are Associated With the SR Ca 2+ Leak
ROS signaling plays a role in the regulation of RyR channel gating by promoting redox post-translational modifications. 3, 24, 25 In particular, oxidative stress induces RyR2 to leak Ca 2+ from the SR. 19 We found that SR Ca 2+ leak at either 23°C or 37°C ( Figure 2A ) correlated with the rate of ROS production ( Figure 2B , as measured with dichlorofluoresceine in an IonOptix system) in both WT and NOS1 −/− cardiomyocytes. ROS was increased at 23°C compared with 37°C in WT, whereas in NOS1 −/− the leak was lower at 23°C compared with physiological temperature ( Figure 2B ). To verify that ROS mediates SR Ca 2+ leak-temperature dependence, we first tested the effect of the superoxide scavenger Tempol on Ca 2+ leak at 23°C, 30°C, and 37°C. Tempol eliminated the Ca 2+ leak in both WT (P<0.0001) and NOS1 −/− (P<0.0001) cardiomyocytes within the range of temperatures ( Figure 2C-2E ), confirming the importance of ROS in the gating of RyR2 channels in both models. We further investigated the involvement of xanthine oxidoreductase (XOR), a superoxide-generating enzyme. As shown above, ROS is primarily elevated in NOS1 −/− at 37°C and WT at 23°C. Oxypurinol reduced ROS in XOR-treated cells ( Figure 3A and 3B) and Ca 2+ leak in NOS1 −/− cardiomyocytes ( Figure 3C ). The SR Ca 2+ leak-load relationship was virtually identical in NOS1 −/− under control conditions or oxypurinol between 23°C and 30°C (K +Oxy =0.0089±0.0045 versus K (−)Oxy =0.0048±0.0024, P=0.475; Figure 3D ), whereas at 34°C and 37°C oxypurinol-treated NOS1 −/− cardiomyocytes exhibited a leak-load curve that was less steep than NOS1 −/− control (K +Oxy =0.0030±0.0025 versus K (−)Oxy =0.0117±0.0015, P=0.0481 at 37°C; Figure 3E ).
Involvement of NO in the Temperature-Mediated Changes in SR Ca 2+ Leak
To test whether defective NO production was the only cause for the biphasic response of SR Ca 2+ leak to changes in temperature, we supplemented the bathing buffer with the NO donor SNAP. At temperatures >30°C, 1 μmol/L SNAP decreased the leak in NOS1 −/− and were equivalent to the levels observed in WT cardiomyocytes. As predicted by our hypothesis, at the lower temperatures (23°C and 25°C), 1 μmol/L SNAP increased the leak in NOS1 −/− to the WT values ( Figure 4A) . Surprisingly, 50 μmol/L SNAP did not significantly affect the leak in NOS1 −/− cardiomyocytes (Online Figure II) . Thus, only 1 μmol/L SNAP was able to restore the normal SR Ca 2+ leaktemperature pattern in NOS1 −/− cardiomyocytes, suggesting that regulation of SR Ca 2+ in diastole is extremely sensitive to the level of NO, at least under this particular condition of exogenous supply of NO by SNAP. Next, we used 100 μmol/L l-VNIO to specifically inhibit NOS1 in WT cardiomyocytes. This approach allowed us to test whether acute inhibition of this isoform was sufficient to mimic the leak-temperature pattern observed in the genetically modified model. Consistently, l-VNIO reduced the leak at 23°C and increased it at 37°C as expected ( Figure 4B ).
Reduced SR Ca 2+ Leak is Associated With Low ROS Levels in a GSNO Reductase Deficiency Model
As shown above, aberrant S-nitrosylation and the redox state of cardiomyocytes affects SR Ca 2+ leak. Deficiency of GSNOR also induced an aberrant NO/redox state with hyper S-nitrosylation of a broad spectrum of proteins. 26 Snitrosylation is thought to exert a protective role against an oxidative environment, thus the levels of ROS in GSNOR −/− cardiomyocytes were lower than those in WT at 23°C but not at 37°C ( Figure 5A and B). Consistent with the results shown above, where the extent of the leak is proportional to the amount of ROS, the GSNOR −/− model exhibited lower leak compared with WT cardiomyocytes at subphysiological temperatures ( Figure 5C ; P=0.001; at matched SR Ca 2+ load, insert). Importantly, the leak at 37°C in GSNOR −/− was not different, regardless of the lower ROS level, compared with WT, agreeing with our previous findings. 21 Surprisingly, the treatment of GSNOR −/− cardiomyocytes with 100 μmol/L hydrogen peroxide (H 2 O 2 ), an oxidant agent that induces cardiomyocyte oxidative stress, did not change SR Ca 2+ leak in this model ( Figure 5C ), suggesting that the supposed protective role of hyper S-nitrosylation might be in part because of enhanced cellular antioxidant mechanisms.
SR Ca 2+ Stores are Primarily Affected by Elevated Leak Under NO/Redox Imbalance
The SR Ca 2+ content of cardiomyocytes paced at 1 Hz was estimated by caffeine challenge. WT and GSNOR −/− cardiomyocytes exhibited a relatively stable Ca 2+ content throughout the studied range of temperatures. Surprisingly, despite the different behavior of leak in GSNOR −/− compared with WT cardiomyocytes when the temperature drops, the average Ca 2+ loads were not different throughout the broad range of studied temperatures ( Figure 6A ). In contrast, the SR Ca 2+ content in NOS1 −/− was higher at 23°C to 25°C than at 34°C to 37°C. At the low range of temperature, SR Ca 2+ content was elevated in NOS1 −/− cardiomyocytes compared with WT or GSNOR −/− . However, at a physiological range of temperatures (34°C-37°C), the Ca 2+ load was significantly reduced in NOS1 −/− cells ( Figure 6A ). Thus, there was a significant correlation between the SR Ca 2+ leak and the resulting average SR Ca 2+ content in NOS1 −/− ( Figure 6B ; R 2 =0.9014) but not in WT (R 2 =0.0189) or GSNOR −/− (R 2 =0.3553) cardiomyocytes. These results suggest that Ca 2+ stores in the NO/redox imbalance model are highly dependent on the leak of Ca 2+ from the SR.
Coupling of NO Synthase and NO Production
NO production was assessed in cardiomyocytes from WT mice to verify that intracellular NOS-derived NO generation is dependent on temperature. NO levels increased because the temperature increased from 23°C to 37°C ( Figure 7A ) as described previously for activity of NOS1, NOS2, and NOS3 in vitro. 14 NO production at the different temperatures was inversely correlated with the Ca 2+ leak (at matched SR Ca 2+ load) in WT cardiomyocytes (R 2 =0.9812; Figure 7B ). This association suggests that temperature-dependent NOS activity plays an important role in SR Ca 2+ leak regulation. We measured SR Ca 2+ leak in WT cardiomyocytes at 23°C in the presence of tetrahydrobiopterin (BH 4 ), a NOS cofactor which also contributes to maintain the functional quaternary structure (dimer) of the enzyme. Interestingly, there was a time-dependent reduction in leak (P=0.066 with 2 minutes preincubation and P=0.011 with 20 minutes preincubation; Figure 7C ), suggesting that the elevated leak at room temperature is mediated by NOS1 uncoupling. In addition, we examined the relationship between temperature and expression of NOS1, NOS2, and NOS3 in WT cardiomyocytes exposed to 23°C, 30°C, and 37°C for 30 minutes. No differences were seen in the amount of mRNA of each isoform in response to temperature change ( Figure 7D ), further suggesting that dependence of NO production on temperature is regulated by the activity rather than expression of NOS isoforms.
Discussion
These findings reconcile a central, 15-year-old controversy in NO cardiobiology; temperature profoundly affects SR Ca 2+ leak. These results explain why experiments on isolated myocytes when performed at room temperature yield different findings to those performed at physiological temperatures. 8, 9 We previously showed that leak was increased in the absence of NOS1 at 37°C, whereas Wang et al 8 showed a reduced leak at room temperature compared with WT control cardiomyocytes. Therefore, we have highlighted that the thermal dependence of the cardiomyocyte metabolism tightly affects the redox state of the cell, which modifies RyR2 activity and thereby SR Ca 2+ leak. At low temperatures, RyR2 gating is favored, 10, 11 and may be associated with reduced NOS activity. 14 It has been proposed that XOR and NOS1 colocalize in the SR in close proximity to RyR2. Thus, NOS1-mediated NO production exerts a powerful inhibitory effect on myocardial XOR and tightly controls RyR2 channel activity. Therefore, a decrease or absence of NOS1 activity leads to a rise in superoxide anion 27 and dysregulation of RyR2-mediated Ca 2+ release. We consistently found increased ROS generation in WT cardiomyocytes when cooled from 37°C to 23°C. This effect was primarily XOR-mediated because inhibition of this enzyme with oxypurinol prevented the rise of ROS at 23°C. We speculate that the limited availability of NOS1-derived NO in this microenvironment is still sufficient to account for the differences in the leak between WT and NOS1 −/− at 23°C in the presence of ROS. The interaction of NO with superoxide yields peroxynitrite, a highly reactive molecule that is more RyR2-damaging than ROS. 15, 28 Consistent with observations in NOS1 −/− cardiomyocytes that the complete absence of NOS1-derived NO is associated with greatly enhanced XOR activity, 18, 27 the reduction in ROS by oxypurinol was associated with reduced SR Ca 2+ leak. In addition, the complete elimination of ROS by Tempol, abolished the leak-temperature dependence either in WT or NOS1 −/− cardiomyocytes, confirming the key role of ROS in this process. Other sources of ROS might play a signaling role, affecting the Ca 2+ leak control. For instance, mitochondrial-derived ROS may be significantly affected by temperature as a result of changes in the electron flow through the respiratory chain. 29 Indeed, hypothermic preconditioning activates mitochondrial ROS release and ERK activation in ventricular myocytes. 30 Moreover, additional evidence that ROS are associated with leak is the fact that, at subphysiological temperatures, where the leak is reduced in GSNOR −/− compared with WT cardiomyocytes, there is also less ROS. In this regard, RyR2 is a highly redox-sensitive Ca 2+ channel and its activity is increased by oxidizing agents and decreased by reducing agents. However, its regulation is even more complex. Thus, the intracellular NO/redox equilibrium is a critical factor determining the responsiveness to Ca 2+ of the RyR2 channel. Post-translational modifications of RyR2, such as S-glutathionylation 31 or S-nitrosylation, 18, 19 are considered protective against irreversible oxidation of redox-sensitive cysteine residues on this channel. As shown previously, 21 the leak in GSNOR −/− cardiomyocytes was not different from WT at 37°C, consistent with there being no difference in ROS, and suggesting that enhanced S-nitrosylation caused by deficient denitrosylation activity, would not affect leak at physiological temperature. In contrast to WT, decreasing temperature did not increase the leak in GSNOR −/− cells, which could indicate a redox-protective effect of S-nitrosylation at subphysiological temperatures. Further evidence for this hypothesis is the fact that the exposure of GSNOR −/− cardiomyocytes to an oxidative stimulus was not sufficient to break down this redox-protective shield mediated by hyper S-nitrosylation.
We mentioned above that a lack of NOS1-derived NO production may be the underlying cause of the atypical SR Ca 2+ leak-temperature pattern in cardiomyocytes from NOS1 −/− mice. We have shown that restoring the NO supply in this model rescues the pattern of high leak at room temperature and low leak at the physiological range of temperatures as observed in WT cardiomyocytes. However, there is a complexity to NO signaling which is evidenced in this work by the ability of 1 μmol/L but not 50 μmol/L of SNAP to elicit such an effect. We previously showed a triphasic response of SR Ca 2+ leak to increasing doses of nitroglycerin in NOS1 −/− cardiomyocytes, 9 thus the effects of exogenously added NO are highly dependent on the concentration and the nature of the NO donor. Accordingly, the idea that reduced NOS1 activity promotes a local microenvironment for this particular behavior of SR Ca 2+ leak, explains the specific inhibition of NOS1 in WT cardiomyocytes yielding results consistent with those in the NOS1 knockout model. As expected, the high leak at 23°C in WT was abolished and the low leak at 37°C was increased by l-VNIO. However, the effect was less robust at the physiological temperature because this increase was only half the level of the leak observed in NOS1 −/− at this temperature. We speculate that the intracellular metabolism of the drug might be different at 37°C and therefore, the effective concentration of l-VNIO might not be sufficient to efficiently inhibit NOS1. Alternatively, the time of exposure to the inhibitor may not be adequate to generate the characteristic NO/redox imbalance as seen by the chronic deletion of NOS1. The risk of using a higher dose of l-VNIO is the loss of specificity. Thus, we confirmed that defective NOS1-derived NO production leads to an NO/redox imbalance that differentially affects SR Ca 2+ leak at physiological or subphysiological temperatures in isolated cardiomyocytes.
Reduced activity of NOS1 at low temperature may be the cause of increased XOR-mediated ROS in WT cardiomyocytes. Moreover, this redox dysregulation would uncouple NOS1, further contributing to ROS production (see the proposed working model in Figure 8 ). Thus, recoupling of NOS1, as mediated by BH 4 treatment, restores the redox balance and leads to low levels of SR Ca 2+ leak. It was recently shown that BH 4 supplementation restores NO production and Snitrosylation of proteins, in cardiomyocytes from a model of dystrophic cardiomyopathy exhibiting oxidative stress. 20 It has been demonstrated previously that NO-mediated Snitrosylation of RyR2 enhances its activity. 3, 32 However, it is important to differentiate activation of the channel from a leaky channel. RyR2 activity is regulated by many factors, including Ca 2+ , phosphorylation, S-nitrosylation, oxidation, etc. Despite activation, the channel might be more or less stabilized, exhibiting different levels of diastolic Ca 2+ leak. Recent studies have associated low S-nitrosylation levels with increased leak measured at 37°C in different models [18] [19] [20] suggesting that NO-mediated S-nitrosylation reduces leak. Here, we propose that temperature is a variable that, by affecting the NO/redox balance, may change the response of RyR2 to exogenous NO.
Ca 2+ stores in NOS1 −/− cardiomyocytes are highly dependent on the leak of Ca 2+ from the SR, because increased leak at higher temperature is associated with depleted SR and vice versa. In addition to the increased leak at 37°C, a slow Ca 2+ decay (Online Figure III) also contributes to the depletion of SR Ca 2+ stores at this temperature in NOS1 −/− . However, Ca 2+ decay is not different from WT at 23°C (Online Figure III) , thus the decreased Ca 2+ leak would be enough to explain the augmented Ca 2+ content at low temperature. This dependence allows us to speculate that SR Ca 2+ stores in this model of NO/ redox imbalance are poorly regulated. There was no obvious association between SR Ca 2+ content and leak within the range of temperatures studied in WT myocytes, suggesting that despite reduced Ca 2+ decay with decreasing temperature (Online Figure III) , it may be enough to compensate for the increased leak in normal mice. Similarly, SR Ca 2+ content was not significantly affected by leak in GSNOR −/− cardiomyocytes. We would expect an enhanced SR filling in GSNOR −/− because they exhibit not only lower leak at subphysiological temperatures but also faster Ca 2+ reuptake than WT (Online Figure III) . Paradoxically, we did not observe such a response. We do not have a logical explanation for these results, but just speculations of a tight set point for the SR filling as a consequence of the hyper S-nitrosylation phenotype. Further investigations of this model of aberrant S-nitrosylation should elucidate the underlying mechanisms.
Potential Implications
Several studies have investigated the effect of hypothermic preconditioning 30, 33, 34 or hypothermia [35] [36] [37] [38] on ischemia-reperfusion and myocardial infarction. These studies demonstrate that therapeutic hypothermia profoundly prevents the deleterious effects induced by these experimental models of myocardial injury. Therapeutic hypothermia is broadly tested in clinical trials and protocols are still being optimized with the main goal of reducing neurological impairment after cardiac arrest. [39] [40] [41] However, the understanding of its benefits on cardioprotection is limited. Reducing temperature in a normal healthy heart increases the Ca 2+ leak, which would be detrimental to the myocardium. Although this effect of cooling does not seem to be protective for healthy cardiomyocytes, the perspective changes when the scenario switches to a highly aggressive condition, such as ischemia-reperfusion, where a burst of ROS is released and the NO/redox equilibrium is disrupted. Indeed, the latter situation is better represented by the NO/redox imbalance described for NOS1 −/− hearts at physiological temperature. On reperfusion, the ischemic myocardium undergoes oxidative stress, 42, 43 which may also activate Ca 2+ /calmodulin-dependent protein kinase II, 44, 45 leading to Ca 2+ handling abnormalities, including SR Ca 2+ leak, 46 which is characteristic in cardiomyocytes with NOS1 deletion. Therefore, inhibition of NOS1 during therapeutic hypothermia could avoid peroxynitrite formation, and might yield better results in terms of reducing spontaneous SR Ca 2+ release into the cytosol, thereby improving cardioprotection and the Figure 7 . Nitric oxide (NO) synthase uncoupling increases leak at low temperature in wild-type (WT) cardiomyocytes. A, NO generation in WT cardiomyocytes measured by detection of diaminofluorescein (DAF-2) at 23°C, 25°C, 30°C, 34°C, or 37°C. Fluorescence was expressed as relative fluorescence units (F/F 0 ) by normalization of the DAF-2 signal at each temperature (F) to the fluorescence at 23°C (F 0 ; n=4 mice; *P<0.05 vs 23°C; 1-way ANOVA). B, Linear correlation between sarcoplasmic reticulum (SR) Ca 2+ leak and NO production in WT cardiomyocytes at all studied temperatures. C, SR Ca 2+ leak (at matched SR Ca 2+ load ≈75 μmol/L) in WT cardiomyocytes in the absence (baseline [BL]) or the presence of 100 μmol/L tetrahydrobiopterin (BH 4 ) for 2 or 20 minutes (*P<0.05; Student t test). D, mRNA content of nitric oxide synthase (NOS)-1, NOS2, and NOS3 in WT cardiomyocytes exposed to 23°C, 30°C, and 37°C for 30 minutes (n=4; Student t test).
outcomes of this powerful intervention. Alternatively, according to our data, inhibition of GSNOR during hypothermia may also add substantial improvements to this protocol because Ca 2+ leak is kept low during cooling in the GSNOR-deficient model.
Conclusion
Here, we show that Ca 2+ leak increases when the temperature drops, coinciding with an XOR-mediated increase in ROS production and NOS1 uncoupling. In contrast, the leak rises at temperatures >30°C in the absence of NOS1 activity and is also associated with elevated ROS. Deficient denitrosylation has a protective role by maintaining low leak levels independent of the temperature. These results suggest that Ca 2+ leak from the SR is regulated by a crucial interaction between temperature and NO/redox balance.
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